Invention Grant
- Patent Title: Modified vaccinia virus strains for use in diagnostic and therapeutic methods
-
Application No.: US15910525Application Date: 2018-03-02
-
Publication No.: US10584317B2Publication Date: 2020-03-10
- Inventor: Aladar A. Szalay , Alexa Frentzen , Yong A. Yu , Nanhai Chen , Qian Zhang
- Applicant: Genelux Corporation
- Applicant Address: US CA San Diego
- Assignee: Genelux Corporation
- Current Assignee: Genelux Corporation
- Current Assignee Address: US CA San Diego
- Agency: Dentons US LLP
- Agent Stephanie Seidman
- Main IPC: C12N7/00
- IPC: C12N7/00 ; A61K39/12 ; A61K38/48 ; A61K9/00 ; A61K31/282 ; A61K31/4745 ; A61K31/7068 ; A61K33/24 ; A61K38/17 ; A61K38/20 ; A61K39/285 ; A61K45/06 ; A61K48/00 ; A61K49/00 ; A61K49/14 ; A61K49/18 ; C07K14/005 ; C07K14/54 ; C07K16/22 ; C12N15/86 ; C12Q1/04 ; G01N33/574 ; G01N33/58 ; A61K38/36 ; A61K35/76 ; A61K39/395 ; C07K14/47 ; C07K14/715 ; A61K39/00
Abstract:
Modified viruses and methods for preparing the modified viruses are provided. Vaccines that contain the viruses are provided. The viruses can be used in methods of treatment of diseases, such as proliferative and inflammatory disorders, including cancer, and as anti-tumor and/or antiangiogenic agents. The viruses also can be used in diagnostic methods.
Public/Granted literature
- US20180195050A1 MODIFIED VACCINIA VIRUS STRAINS FOR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS Public/Granted day:2018-07-12
Information query
